Pays: Royaume-Uni
Langue: anglais
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Latanoprost
Martindale Pharmaceuticals Ltd
S01EE01
Latanoprost
50microgram/1ml
Eye drops
Ocular
No Controlled Drug Status
Valid as a prescribable product
BNF: 11060000; GTIN: 5026468744503
1 PACKAGE LEAFLET: INFORMATION FOR THE USER LATANOPROST 0.005% W/V EYE DROPS SOLUTION READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you or for your child only. Do not pass it on to others. It may harm them, even if their symptoms of illness are the same as yours. - If you get any side effects, talk to your doctor or the doctor treating your child or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Latanoprost eye drops is and what it is used for 2. What you need to know before you use Latanoprost eye drops 3. How to use Latanoprost eye drops 4. Possible side effects 5. How to store Latanoprost eye drops 6. Contents of the pack and other information 1. WHAT LATANOPROST EYE DROPS IS AND WHAT IT IS USED FOR Latanoprost eye drops belongs to a group of medicines known as prostaglandin analogues. It lowers the pressure within your eye by increasing the natural flow of fluid from inside the eye into the blood stream. Latanoprost eye drops is used to treat adults with open angle glaucoma and ocular hypertension. These conditions are linked with an increase in the pressure within your eye. If they are not treated they may affect your eyesight. Latanoprost eye drops is also used to treat increased eye pressure and glaucoma in all ages of children and babies. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE LATANOPROST EYE DROPS Latanoprost eye drops can be used in adults (including the elderly) and in children from birth to 18 years of age. Latanoprost eye drops has not been investigated in prematurely born infants (less than 36 weeks gestation). DO NOT USE LATANOPROST EYE DROPS - if you are ALLERGIC (hypersensitive) to latanoprost or any of the other ingredients of Latanoprost eye drops (listed in section 6) - if you are Lire le document complet
OBJECT 1 LATANOPROST 0.005% W/V EYE DROPS SOLUTION Summary of Product Characteristics Updated 09-Dec-2016 | Martindale Pharma 1. Name of the medicinal product Latanoprost 0.005% w/v eye drops solution. 2. Qualitative and quantitative composition Each millilitre (ml) of latanoprost eye drops solution contains 50 mcg of latanoprost. One drop contains approximately 1.5 micrograms latanoprost. Excipient with known effect: Benzalkonium chloride 0.02% w/v as a preservative. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Eye drops, solution. The solution is a clear colourless liquid. 4. Clinical particulars 4.1 Therapeutic indications Reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. Reduction of elevated intraocular pressure in paediatric patients with elevated intraocular pressure and paediatric glaucoma. 4.2 Posology and method of administration Posology _Recommended dosage for adults (including the elderly):_ Recommended therapy is one eye drop in the affected eye(s) once daily. Optimal effect is obtained if Latanoprost eye drops is administered in the evening. The dosage of Latanoprost eye drops should not exceed once daily since it has been shown that more frequent administration decreases the intraocular pressure lowering effect. If one dose is missed, treatment should continue with the next dose as normal. Method of administration As with any eye drops, to reduce possible systemic absorption, it is recommended that the lachrymal sac be compressed at the medial canthus (punctal occlusion) for one minute. This should be performed immediately following the instillation of each drop. Contact lenses should be removed before instillation of the eye drops and may be reinserted after 15 minutes. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five minutes apart. _Paediatric population_ Latanoprost eye drops may be used in paediatric patients at the same posology as in adults. No data are avail Lire le document complet